We warmly celebrate the successful opening ceremony of Siraimei Biotechnology (Zhejiang) Co., Ltd. Hangzhou Branch!

Business is like spring, new lines triumph over old ones.

Yingmen Feijiu, Yun Opening Ceremony Spring Breeze.

On November 25, 2022, the wholly-owned subsidiary of Zhejiang Xingyue Biotechnology Co., Ltd., Siraimei Biotechnology (Zhejiang) Co., Ltd. Hangzhou Branch, held a grand opening ceremony in Hangzhou. On the day of the event, more than 80 people, including Xuan Tiefeng, General Manager of Zhejiang Xingyue Biotechnology Co., Ltd. and Siluimei Biotechnology (Zhejiang) Co., Ltd., Zhang Xiao, Zhao Hongshi, Chen Longkun, Deputy General Manager of Xingyue Biotechnology, Wang Fang, Assistant General Manager, Yu Jinyou, Head of Hangzhou Branch of Siluimei Biotechnology (Zhejiang) Co., Ltd., Xie Jing, Director of Raw Materials and Beauty Business Unit of Siluimei Biotechnology (Zhejiang) Co., Ltd., and all employees of Xingyue Biotechnology and Siluimei Biotechnology, attended the opening ceremony together, enjoying the beauty and glory of the event！

Xuan Tiefeng, General Manager of Zhejiang Xingyue Biotechnology Co., Ltd. and Siraimei Biotechnology (Zhejiang) Co., Ltd., stated that as a wholly-owned subsidiary of Xingyue Biotechnology, Siraimei Biotechnology has grown rapidly with the strong support of Xingyue Group, especially Mr. Hu Jirong, the CEO of the group. Last year, Siraimei Biotechnology began establishing a production base in Yongkang, and large-scale (automated) production line construction is in full swing, which will become the production capacity guarantee for the company's medical beauty products; This year, the Siluimei branch, which focuses on research and development and sales, was established by the beautiful West Lake and grandly opened today. This is an important symbol of Xingyue Biotechnology's 12 year journey from research and development to market, indicating the comprehensive launch of Xingyue Biotechnology's medical beauty product marketing work. The company's more than ten years of dedicated research on medical silk protein will move from the laboratory to the vast medical beauty market, benefiting the public with its scientific research achievements. If we compare the preparation of the Star Moon Creatures in the first 12 years to the runway taxiing before an airplane takes off, then the establishment of Sirei Mei today is the accumulation and development of flying high into the sky. I believe that with the personal guidance of Mr. Hu Jirong, the CEO of the group, and the joint efforts of everyone, we will definitely fly higher, faster, and farther.

The horn of sailing has sounded, and we will take note of this exciting moment to jointly write a new chapter in the development of silk fibroin in the field of medical aesthetics, and create a more brilliant future for the silk fibroin industry.